SentiSense Logo

SentiSense

Ctrl+K

55% OFF

Quick tip: Press

K

to search stocks

A

ABT

Abbott Laboratories

$109.56

-1.48 (-1.33%)

Summary

Stories

News

Metrics

Fundamentals

Current Market Valuation

Current Price

$109.56

Live market price

P/E (TTM)

15.58

EPS: $7.03

P/S (TTM)

5.86

Price to Sales

TTM Quarters

3

Quarters included in TTM

Updated: 3/8/2026, 10:24:12 PM

Historical Trends

Range:

Revenue Over Time

Q1 2021Q1 2022Q1 2023Q1 2024Q2 2025$0B$3B$6B$9B$12B

Net Income Over Time

Q1 2021Q1 2022Q1 2023Q1 2024Q2 2025$0B$3B$6B$9B$12B

Short Interest (% of Float) Over Time

02/2805/3008/2902/130.0%5.0%10.0%15.0%20.0%High SI

Short Interest

17.2M

% of Float

1.0%

Days to Cover

1.5

Avg Daily Vol

11.4M

Historical income statement data up to 5 years


Historical SEC Filings

Report Period

Debt/Equity

0.25

Leverage ratio

ROE (TTM)

12.36%

Return on equity

Income Statement

Revenue

$44.33B


Cost of Revenue

$19.32B


Gross Profit

$25.01B


Operating Income

$8.05B


Net Income

$6.52B


EPS (Quarter)

$3.72


EPS (TTM)

--

Balance Sheet

Total Assets

$86.71B


Total Liabilities

$33.94B


Shareholders' Equity

$52.77B


Current Assets

$26.00B


Current Liabilities

$16.50B


Cash & Equivalents

--


Long-Term Debt

$12.93B

Cash Flow

Operating Cash Flow

$9.57B


Investing Cash Flow

$-2.42B


Financing Cash Flow

$-6.31B


Free Cash Flow

$7.14B

Profitability Margins

Gross Margin

56.42%

Operating Margin

18.17%

Net Profit Margin

14.72%


ROA (TTM)

7.52%


ROE (TTM)

12.36%

Data source: Polygon.io

Last updated: 3/8/2026, 10:24:12 PM

Company Profile

Symbol

ABT


Market Cap

$190.38B


IPO Date

Apr 19, 1949


CEO

Robert B. Ford


Employees

115,000


Sector

--


Industry

PHARMACEUTICAL PREPARATIONS


Country

United States


Exchange

--

Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.

Read More

Similar Stocks

MRK

Merck & Co., Inc.

$115.79

-0.24%

BSX

Boston Scientific Corporation

$71.35

-2.25%

MDT

Medtronic plc

$90.90

-2.27%

DHR

Danaher Corporation

$195.50

-3.22%

SentiSense Logo

SentiSense

Sense what the market is doing.

© 2026 Compass AI Data Services, LLC. All rights reserved.


Important Disclaimer: Compass AI Data Services, LLC provides market information, sentiment analysis, and data intelligence. We do not provide investment advice, recommendations, or financial guidance. All information is for informational purposes only. Users are solely responsible for their own investment decisions. Always consult a licensed financial advisor before making investment decisions.

Cookie Preferences

We use cookies to enhance your experience and analyze site traffic. Privacy Policy